Viewing nowHynav 60 mg Tablet (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

MFDS item code 202402894 · Approved 2024.12.06 · Insurance code 649106060
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is persistently high, and this medication is used to control these hypertension symptoms and stabilize blood pressure.
1. Essential hypertension ⦁ Adults The recommended dose of this medication is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, the dose may be increased to 120 milligrams once daily. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. ⦁ Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. For elderly patients over 70 years of age, an initial dose of 30 mg of this medication once daily is recommended. (See section 9. Administration to elderly patients under Precautions for Use.) ⦁ Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. ⦁ Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medication should not be administered to patients with moderate ~ severe hepatic impairment (see sections 2. Patients Who Must Not Receive This Medication and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). ⦁ Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Administration with Caution under Precautions for Use.)
⦁ Children The safety and efficacy of this medication have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication can cause serious harm or death to the fetus or newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to the ingredients of this medication, those who are pregnant or breastfeeding, patients undergoing renal dialysis, patients with moderate to severe liver dysfunction, patients with biliary obstruction, diabetic patients with certain kidney diseases, and those with genetic issues such as lactose intolerance should not take this medicine. Patients with low blood volume or sodium, patients with impaired kidney function, patients with renovascular hypertension, patients with aortic and mitral valve stenosis, patients with primary aldosteronism, and those allergic to the pigment in this medication should use it with caution. While taking this medication, symptoms such as headaches and dizziness may commonly occur, and rare side effects such as dyspepsia, vomiting, liver function abnormalities, cough, muscle stiffness, skin rash, and blood pressure changes have been reported. If blood pressure drops too low or severe side effects occur, immediate medical attention should be sought. Since this medication lowers blood pressure, caution is needed as blood pressure may drop sharply when starting treatment if patients are on high-dose diuretics or have restricted salt intake. Additionally, as there is a risk of increased potassium levels in the blood, regular blood tests are recommended. Interactions may occur when taken with other blood pressure medications, certain diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so consultation with a doctor or pharmacist is essential. Women who are pregnant or breastfeeding should avoid taking this medication, and especially during early pregnancy, it may also pose risks, so if planning to become pregnant or upon discovering a pregnancy, it should be discontinued immediately. Safety and effectiveness in children under 18 years have not been established. Elderly patients over 65 years may be more sensitive to this drug, hence caution is required. Patients with moderate to severe liver disease should not take this medication. In case of overdose, symptoms such as hypotension and cardiac arrhythmias may occur, and if symptoms arise, immediate medical attention should be sought. This medication should be kept out of reach of children and should not be transferred to other containers.
Headache, dizziness, fainting, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase activity, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colon carcinoma, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pulmonary fibrosis, pharyngitis, pneumonia, lung disease, death, exacerbation of low back pain, osteoarthritis, arthralgia, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, elevated blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, low back pain, edema, limb pain, peripheral edema, facial edema, fatigue, fever, neck/shoulder pain, fracture, arthralgia, osteoporosis, myalgia, pharyngitis, upper respiratory tract infection, sputum, rhinitis, epistaxis, bronchitis, sensory abnormalities, numbness, tremors, excessive muscle tension, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional bowel disorder, worsening chronic renal failure, dysuria, hyperlipidemia, dyslipidemia, purpura, fatty liver, tinnitus, hearing impairment, hearing loss, pelvic inflammatory disease, vaginitis, benign prostatic hyperplasia, scrotal pain, blood pressure fluctuations, localized inflammation, soft tissue inflammation, lymphadenopathy, postoperative pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that blocks light, at temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the medication’s effectiveness.
Yellow oval film-coated tablet with a break line on one side
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Dongkuk Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.